Pregled bibliografske jedinice broj: 1097714
Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates
Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates // The Journal of infection, 81 (2020), 3; e99-e100 doi:10.1016/j.jinf.2020.05.022 (međunarodna recenzija, pismo, znanstveni)
CROSBI ID: 1097714 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cardiac troponins predict mortality in patients
with COVID-19: A meta-analysis of adjusted risk
estimates
Autori
Vrsalović, Mislav ; Vrsalović Presečki, Ana
Izvornik
The Journal of infection (0163-4453) 81
(2020), 3;
E99-e100
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni
Ključne riječi
troponin ; mortality ; CoVID 19 ; meta-analysis
Sažetak
Critical illness and sepsis are often associated with a troponin rise. Therefore, troponin, in daily clinical practice, is frequently used as a marker of disease severity and as a predictor of future unfavourable outcomes. Recently, several studies investigated the prognostic role of biomarkers of myocardial injury (i.e. troponins) with mortality in hospitalized patients with coronavirus disease 2019 (COVID-19). Of note, those meta-analyses included studies that reported primarily unadjusted effect estimates of in- hospital mortality with higher troponin levels. Compared to patients with normal troponin levels, those with elevated troponins and consequently worse outcome were older and had higher rates of comorbidities including coronary artery disease, hypertension, chronic kidney disease, and diabetes. As a consequence, the final results of those studies showed a significant heterogeneity and markedly different risk estimates of mortality .Therefore, we systematically searched Medline and Scopus to identify all observational cohort studies that compared outcome (in-hospital mortality) in consecutive patients hospitalized with COVID-19 with and without troponin elevation. A meta-analysis of studies that reported adjusted effect estimates was conducted using the generic inverse variance method, and heterogeneity between studies was investigated using the Cochrane‘s Q test and I2 statistic. Publication bias was assessed graphically using a funnel plot. From these we concluded that troponin positivity is common in hospitalised COVID-19 patients, and may serve as an additional risk stratification tool in everyday clinical setting.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb,
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)